Johnson & Johnson pauses COVID-19 vaccine study over participant illness

Johnson & Johnson pauses COVID-19 vaccine study over participant illness


Johnson & Johnson has paused clinical trials of its experimental coronavirus vaccine over “an unexplained illness” in one of the study’s participants, the company announced Monday.

“We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant,” the company wrote in a statement.

The company did not disclose any details about the reported illness, but said the participant is being evaluated by an internal monitoring board and physicians.

Trending: 'Seinfeld' Cast Members Pushing Fundraising Effort to Turn Texas Blue: 'Texas Has Never Been a Red State'

“We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” Johnson & Johnson wrote.

The study pause was first reported by Stat News.

The company said in its statement that illnesses during clinical trials are not uncommon.

“Adverse events – illnesses, accidents, etc. – even those that are serious, are an expected part of any clinical

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!